Clinical trials
Phase 2 Fibrosis trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2017 | 2 |
| 2019 | 1 |
| 2021 | 1 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Terminated | 3 |
| Active, not recruiting | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gilead Sciences | 2 |
| AstraZeneca | 1 |
| Axcella Health, Inc | 1 |
| Celgene | 1 |
| Intercept Pharmaceuticals | 1 |
| Inventiva Pharma | 1 |
| Mediar Therapeutics | 1 |
| Ocera Therapeutics, Inc. | 1 |
| Pulmovant, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fibrosis | 10 |
| Idiopathic Pulmonary Fibrosis | 3 |
| Fatty Liver | 2 |
| Lung Diseases | 2 |
| Lung Diseases, Interstitial | 2 |
| Non-alcoholic Fatty Liver Disease | 2 |
| Cardiovascular Diseases | 1 |
| Digestive System Diseases | 1 |
| Hepatic Encephalopathy | 1 |
| Hepatitis C | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.